| 1 | Glioblastoma-Infiltrating <i>CD8</i>+ T Cells Are Predominantly a Clonally Expanded <i>GZMK</i>+ Effector Population | 25.6 | 42 | Citations (PDF) |
| 2 | Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma | 43.7 | 323 | Citations (PDF) |
| 3 | Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma | 6.9 | 7 | Citations (PDF) |
| 4 | Multielectrode Spectroscopy Enables Rapid and Sensitive Molecular Profiling of Extracellular Vesicles | 9.2 | 26 | Citations (PDF) |
| 5 | Impaired neurogenesis alters brain biomechanics in a neuroprogenitor-based genetic subtype of congenital hydrocephalus | 17.1 | 90 | Citations (PDF) |
| 6 | Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression | 24.2 | 227 | Citations (PDF) |
| 7 | Abstract 5175: Novel approach for glioblastoma characterization via tumor specific extracellular vesicles | 0.6 | 0 | Citations (PDF) |
| 8 | Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition | 4.2 | 45 | Citations (PDF) |
| 9 | Highly Sensitive <i>EGFRvIII</i> Detection in Circulating Extracellular Vesicle RNA of Glioma Patients | 6.9 | 39 | Citations (PDF) |
| 10 | <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas | 6.9 | 79 | Citations (PDF) |
| 11 | A rapid genotyping panel for detection of primary central nervous system lymphomaBlood, 2021, 138, 382-386 | 4.2 | 34 | Citations (PDF) |
| 12 | Blood-Based Detection of BRAF V600E in Gliomas and Brain Tumor Metastasis | 4.0 | 14 | Citations (PDF) |
| 13 | An integrated magneto-electrochemical device for the rapid profiling of tumour extracellular vesicles from blood plasma | 22.6 | 178 | Citations (PDF) |
| 14 | Intraoperative thalamocortical tract monitoring via direct cortical recordings during craniotomy | 1.3 | 11 | Citations (PDF) |
| 15 | Clinical outcomes as a function of the number of samples taken during stereotactic needle biopsies: a meta-analysis | 2.6 | 12 | Citations (PDF) |
| 16 | A Crowdsourced Consensus on Supratotal Resection Versus Gross Total Resection for Anatomically Distinct Primary Glioblastoma | 1.9 | 33 | Citations (PDF) |
| 17 | Predicting Discharge Disposition Following Meningioma Resection Using a Multi-Institutional Natural Language Processing Model | 1.9 | 12 | Citations (PDF) |
| 18 | Large and small extracellular vesicles released by glioma cells <i>in vitro</i> and <i>in vivo</i> | 12.7 | 72 | Citations (PDF) |
| 19 | Radiation-induced extracellular vesicle (EV) release of miR-603 promotes IGF1-mediated stem cell state in glioblastomas | 9.9 | 53 | Citations (PDF) |
| 20 | Orally Administered 5-aminolevulinic Acid for Isolation and Characterization of Circulating Tumor-Derived Extracellular Vesicles in Glioblastoma Patients | 4.0 | 12 | Citations (PDF) |
| 21 | American Neurotology Society, American Otological Society, and American Academy of Otolaryngology – Head and Neck Foundation Guide to Enhance Otologic and Neurotologic Care During the COVID-19 Pandemic | 1.6 | 18 | Citations (PDF) |
| 22 | Toward a Personalized Approach to Parkinson's Cell Therapy | 4.6 | 4 | Citations (PDF) |
| 23 | Novel Gene Fusions in Glioblastoma Tumor Tissue and Matched Patient Plasma | 4.0 | 13 | Citations (PDF) |
| 24 | Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease | 43.7 | 460 | Citations (PDF) |
| 25 | Liquid Biopsy Strategies to Distinguish Progression from Pseudoprogression and Radiation Necrosis in Glioblastomas | 3.5 | 21 | Citations (PDF) |
| 26 | Airborne Aerosol Generation During Endonasal Procedures in the Era of COVID‐19: Risks and Recommendations | 2.4 | 129 | Citations (PDF) |
| 27 | Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state | 2.6 | 31 | Citations (PDF) |
| 28 | FASN Is a Biomarker Enriched in Malignant Glioma-Derived Extracellular Vesicles | 4.5 | 37 | Citations (PDF) |
| 29 | Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies | 2.8 | 295 | Citations (PDF) |
| 30 | Extracellular Vesicles in Glioblastoma Tumor Microenvironment | 5.1 | 130 | Citations (PDF) |
| 31 | From laboratory to clinic: Translation of extracellular vesicle based cancer biomarkers | 3.6 | 85 | Citations (PDF) |
| 32 | Letter: Adaptation Under Fire: Two Harvard Neurosurgical Services During the COVID-19 Pandemic | 1.9 | 33 | Citations (PDF) |
| 33 | Human autologous iPSC–derived dopaminergic progenitors restore motor function in Parkinson’s disease models | 10.7 | 160 | Citations (PDF) |
| 34 | SURG-21. A CROWDSOURCED CONSENSUS ON SUPRATOTAL RESECTION VERSUS GROSS TOTAL RESECTION FOR ANATOMICALLY DISTINCT PRIMARY GLIOBLASTOMA | 1.1 | 0 | Citations (PDF) |
| 35 | STEM-24. RADIATION-INDUCED EXTRACELLULAR VESICLE (EV) RELEASE OF miR-603 PROMOTES IGF1-MEDIATED STEM CALL STATE IN GLIOBLASTOMAS | 1.1 | 0 | Citations (PDF) |
| 36 | Assessing the Understandability and Actionability of Online Neurosurgical Patient Education Materials | 1.5 | 41 | Citations (PDF) |
| 37 | An Integrative Model of Cellular States, Plasticity, and Genetics for GlioblastomaCell, 2019, 178, 835-849.e21 | 34.1 | 2,288 | Citations (PDF) |
| 38 | A Pilot Proof-Of-Principle Analysis Demonstrating Dielectrophoresis (DEP) as a Glioblastoma Biomarker Platform | 3.5 | 35 | Citations (PDF) |
| 39 | CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity | 32.2 | 514 | Citations (PDF) |
| 40 | Smoking As a Risk Factor for Postcraniotomy 30-Day Mortality | 1.5 | 2 | Citations (PDF) |
| 41 | Factors that modify the risk of intraoperative seizures triggered by electrical stimulation during supratentorial functional mapping | 1.3 | 28 | Citations (PDF) |
| 42 | Navigating the Landscape of Tumor Extracellular Vesicle Heterogeneity | 4.5 | 44 | Citations (PDF) |
| 43 | Correlation Structure in Micro-ECoG Recordings is Described by Spatially Coherent Components | 3.1 | 38 | Citations (PDF) |
| 44 | CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma 2019, 7, | | 258 | Citations (PDF) |
| 45 | Characterization of plasma-derived protoporphyrin-IX-positive extracellular vesicles following 5-ALA use in patients with malignant glioma | 9.9 | 34 | Citations (PDF) |
| 46 | The Impact of Unmet Communication and Education Needs on Neurosurgical Patient and Caregiver Experiences of Care: A Qualitative Exploratory Analysis | 1.5 | 10 | Citations (PDF) |
| 47 | Prognostic Importance of Age, Tumor Location, and Tumor Grade in Grade II Astrocytomas: An Integrated Analysis of the Cancer Genome Atlas and the Surveillance, Epidemiology, and End Results Database | 1.5 | 11 | Citations (PDF) |
| 48 | Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles | 11.0 | 542 | Citations (PDF) |
| 49 | Sub-millimeter ECoG pitch in human enables higher fidelity cognitive neural state estimation | 4.4 | 41 | Citations (PDF) |
| 50 | Mapping of genomic EGFRvIII deletions in glioblastoma: insight into rearrangement mechanisms and biomarker development | 1.1 | 34 | Citations (PDF) |
| 51 | Pluripotent stem cell-based therapy for Parkinson’s disease: Current status and future prospects | 5.9 | 120 | Citations (PDF) |
| 52 | Quantification of glioblastoma mass effect by lateral ventricle displacement | 3.5 | 25 | Citations (PDF) |
| 53 | Post-operative imaging assessment of non-functioning pituitary adenomas | 1.6 | 4 | Citations (PDF) |
| 54 | Intraoperative Magnetic Resonance Imaging–Guided Biopsy in the Diagnosis of Suprasellar Langerhans Cell Histiocytosis | 1.5 | 7 | Citations (PDF) |
| 55 | Corrigendum to “Coma and Stroke Following Surgical Treatment of Unruptured Intracranial Aneurysm: An American College of Surgeons National Surgical Quality Improvement Program Study” [World Neurosurgery (2016) 91:272–278] | 1.5 | 1 | Citations (PDF) |
| 56 | Interaction Between the Contributions of Tumor Location, Tumor Grade, and Patient Age to the Survival Benefit Associated with Gross Total Resection | 1.5 | 15 | Citations (PDF) |
| 57 | Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles | 13.9 | 308 | Citations (PDF) |
| 58 | Development and Translation of PEDOT:PSS Microelectrodes for Intraoperative Monitoring | 17.0 | 124 | Citations (PDF) |
| 59 | Risk Factors for Readmission with Cerebrospinal Fluid Leakage Within 30 Days of Vestibular Schwannoma Surgery | 1.9 | 24 | Citations (PDF) |
| 60 | Superior Prognostic Value of Cumulative Intracranial Tumor Volume Relative to Largest Intracranial Tumor Volume for Stereotactic Radiosurgery-Treated Brain Metastasis Patients | 1.9 | 27 | Citations (PDF) |
| 61 | Survival patterns of oligoastrocytoma patients: A surveillance, epidemiology and end results (SEER) based analysis | 0.4 | 4 | Citations (PDF) |
| 62 | ATIM-26. IMMUNOLOGIC TRENDS ASSOCIATED WITH PATIENT OUTCOMES IN A PHASE 1 CLINICAL TRIAL OF TOCA 511 AND TOCA FC IN RECURRENT HIGH GRADE GLIOMA | 1.1 | 1 | Citations (PDF) |
| 63 | NIMG-25. MOLECULAR PHYSIOLOGY OF CONTRAST ENHANCEMENT IN GLIOBLASTOMAS: AN ANALYSIS OF THE CANCER IMAGING ARCHIVE (TCIA) | 1.1 | 0 | Citations (PDF) |
| 64 | SURG-04. SURVIVAL BENEFIT ASSOCIATED WITH GROSS TOTAL RESECTION IN GRADE II ASTROCYTOMAS: AN INTEGRATED ANALYSIS OF THE SEER AND TCGA DATABASE | 1.1 | 0 | Citations (PDF) |
| 65 | RDNA-01. microRNA DEGRADATION MEDIATED GENETIC HETEROGENEITY AS A NOVEL MECHANISM FOR TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA | 1.1 | 0 | Citations (PDF) |
| 66 | 309 Highly Sensitive Detection of the IDH1 R132H Mutation in the Plasma of Glioma Patients | 1.9 | 0 | Citations (PDF) |
| 67 | The role of proton beam therapy in central neurocytoma: A single-institution experience | 2.7 | 1 | Citations (PDF) |
| 68 | Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC | 1.1 | 160 | Citations (PDF) |
| 69 | Molecular physiology of contrast enhancement in glioblastomas: An analysis of The Cancer Imaging Archive (TCIA) | 1.6 | 15 | Citations (PDF) |
| 70 | Cumulative Intracranial Tumor Volume Augments the Prognostic Value of Diagnosis-Specific Graded Prognostic Assessment Model for Survival in Patients with Melanoma Cerebral Metastases | 1.9 | 24 | Citations (PDF) |
| 71 | Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma | 2.4 | 34 | Citations (PDF) |
| 72 | Blood-based biomarkers for the diagnosis and monitoring of gliomas | 1.1 | 83 | Citations (PDF) |
| 73 | Carotid artery stenting vs. carotid endarterectomy in the management of carotid artery stenosis: Lessons learned from randomized controlled trials 2018, 9, 85 | | 17 | Citations (PDF) |
| 74 | Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study | 1.9 | 40 | Citations (PDF) |
| 75 | Clinical efficacy and safety of surface imaging guided radiosurgery (SIG-RS) in the treatment of benign skull base tumors | 2.6 | 27 | Citations (PDF) |
| 76 | Survival trends of oligodendroglial tumor patients and associated clinical practice patterns: a SEER-based analysis | 2.6 | 17 | Citations (PDF) |
| 77 | Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis | 1.5 | 14 | Citations (PDF) |
| 78 | Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients | 1.1 | 203 | Citations (PDF) |
| 79 | Management and Survival Patterns of Patients with Gliomatosis Cerebri: A SEER-Based Analysis | 1.5 | 16 | Citations (PDF) |
| 80 | Ipsilateral Pupillary Dilation Following Carotid Endarterectomy: A Temporary and Benign Phenomenon | 1.9 | 2 | Citations (PDF) |
| 81 | Depression After Spinal Surgery: A Comparative Analysis of the California Outcomes Database | 3.1 | 30 | Citations (PDF) |
| 82 | Coding and noncoding landscape of extracellular RNA released by human glioma stem cells | 13.9 | 484 | Citations (PDF) |
| 83 | The use of TMZ embedded hydrogels for the treatment of orthotopic human glioma xenografts | 1.6 | 9 | Citations (PDF) |
| 84 | Liquid biopsy for brain tumors | 3.2 | 151 | Citations (PDF) |
| 85 | Analysis of extracellular RNA in cerebrospinal fluid | 12.7 | 91 | Citations (PDF) |
| 86 | Survival Patterns of 5750 Stereotactic Radiosurgery–Treated Patients with Brain Metastasis as a Function of the Number of Lesions | 1.5 | 39 | Citations (PDF) |
| 87 | Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume | 1.5 | 25 | Citations (PDF) |
| 88 | Real-time Magnetic Resonance Imaging-Guided Biopsy Using SmartFrame® Stereotaxis in the Setting of a Conventional Diagnostic Magnetic Resonance Imaging Suite | 0.6 | 14 | Citations (PDF) |
| 89 | Rapid Isolation and Detection of Exosomes and Associated Biomarkers from Plasma | 15.3 | 363 | Citations (PDF) |
| 90 | The Association between Psychiatric Comorbidities and Outcomes for Inpatients with Traumatic Brain Injury | 3.7 | 24 | Citations (PDF) |
| 91 | A cerebrospinal fluid microRNA signature as biomarker for glioblastoma | 1.7 | 128 | Citations (PDF) |
| 92 | Differential localization of glioblastoma subtype: implications on glioblastoma pathogenesis | 1.7 | 29 | Citations (PDF) |
| 93 | Characterization and Correction of Geometric Distortions in 814 Diffusion Weighted Images | 2.4 | 163 | Citations (PDF) |
| 94 | Impact of medical academic genealogy on publication patterns: An analysis of the literature for surgical resection in brain tumor patients | 6.3 | 21 | Citations (PDF) |
| 95 | Cumulative Intracranial Tumor Volume (CITV) Enhances the Prognostic Value of the Lung-Specific Graded Prognostic Assessment (GPA) Model | 1.9 | 23 | Citations (PDF) |
| 96 | ‘Journal Bias’ in peer-reviewed literature: an analysis of the surgical high-grade glioma literature | 7.3 | 7 | Citations (PDF) |
| 97 | Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid | 1.6 | 90 | Citations (PDF) |
| 98 | Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Posttreatment Follow-up Evaluation of Patients With Nonfunctioning Pituitary Adenomas | 1.9 | 42 | Citations (PDF) |
| 99 | Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile | 2.5 | 310 | Citations (PDF) |
| 100 | Increased Operative Time for Benign Cranial Nerve Tumor Resection Correlates with Increased Morbidity Postoperatively | 1.1 | 20 | Citations (PDF) |
| 101 | Coevolution of Peer-Reviewed Literature and Clinical Practice in High-Grade Glioma Resection | 1.5 | 5 | Citations (PDF) |
| 102 | Predictors of 30-day perioperative morbidity and mortality of unruptured intracranial aneurysm surgery | 1.4 | 38 | Citations (PDF) |
| 103 | Histologic Evidence for Arteriovenous Malformation-Like Vasculature Occurring within an Intracerebral Schwannoma: A Case Report and Review of the Literature | 1.5 | 5 | Citations (PDF) |
| 104 | Morbid obesity increases risk of morbidity and reoperation in resection of benign cranial nerve neoplasms | 1.4 | 19 | Citations (PDF) |
| 105 | Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma | 12.7 | 182 | Citations (PDF) |
| 106 | Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Preoperative Imaging Assessment of Patients With Suspected Nonfunctioning Pituitary Adenomas | 1.9 | 24 | Citations (PDF) |
| 107 | Future directions of operative neuro-oncology | 2.6 | 6 | Citations (PDF) |
| 108 | Is Patient Age Associated with Perioperative Outcomes After Surgical Resection of Benign Cranial Nerve Neoplasms? | 1.5 | 19 | Citations (PDF) |
| 109 | Coma and Stroke Following Surgical Treatment of Unruptured Intracranial Aneurysm: An American College of Surgeons National Surgical Quality Improvement Program Study | 1.5 | 16 | Citations (PDF) |
| 110 | Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase | 6.9 | 64 | Citations (PDF) |
| 111 | A 22‐Year Old Woman with Right Eyelid Swelling | 4.3 | 0 | Citations (PDF) |
| 112 | Superior Efficacy of Gross Total Resection in Anaplastic Astrocytoma Patients Relative to Glioblastoma Patients | 1.5 | 18 | Citations (PDF) |
| 113 | ExRNA in Biofluids as Biomarkers for Brain Tumors | 4.1 | 23 | Citations (PDF) |
| 114 | Stereotactic Radiosurgery Treatment of Trigeminal Neuralgia: Clinical Outcomes and Prognostic Factors | 1.5 | 32 | Citations (PDF) |
| 115 | Management patterns of patients with cerebral metastases who underwent multiple stereotactic radiosurgeries | 2.6 | 13 | Citations (PDF) |
| 116 | Survival trends of grade I, II, and III astrocytoma patients and associated clinical practice patterns between 1999 and 2010: A SEER-based analysis | 0.9 | 34 | Citations (PDF) |
| 117 | Comparative Analysis of Technologies for Quantifying Extracellular Vesicles (EVs) in Clinical Cerebrospinal Fluids (CSF) | 2.4 | 123 | Citations (PDF) |
| 118 | Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication Consortium | 12.7 | 60 | Citations (PDF) |
| 119 | Extracellular RNAs: development as biomarkers of human disease | 12.7 | 84 | Citations (PDF) |
| 120 | Integration of extracellular RNA profiling data using metadata, biomedical ontologies and Linked Data technologies | 12.7 | 53 | Citations (PDF) |
| 121 | Thirty-Day Perioperative Outcomes in Spinal Fusion by Specialty Within the NSQIP DatabaseSpine, 2015, 40, 1122-1131 | 2.4 | 66 | Citations (PDF) |
| 122 | Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition | 1.7 | 9 | Citations (PDF) |
| 123 | Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion* | 2.2 | 16 | Citations (PDF) |
| 124 | Extracellular vesicles, tissue factor, cancer and thrombosis – discussion themes of the ISEV 2014 Educational Day | 12.7 | 76 | Citations (PDF) |
| 125 | miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients | 2.6 | 152 | Citations (PDF) |
| 126 | Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma | 13.9 | 594 | Citations (PDF) |
| 127 | Intraoperative magnetic resonance imaging assessment of non-functioning pituitary adenomas during transsphenoidal surgery | 2.8 | 23 | Citations (PDF) |
| 128 | Arteriovenous malformation within an isocitrate dehydrogenase 1 mutated anaplastic oligodendroglioma 2015, 6, 295 | | 2 | Citations (PDF) |
| 129 | Informatic system for a global tissue–fluid biorepository with a graph theory–oriented graphical user interface | 12.7 | 4 | Citations (PDF) |
| 130 | BM-08 * PROGNOSTIC FACTORS FOR SRS-TREATED PATIENTS WITH CEREBRAL METASTASIS: IMPLICATIONS ON RANDOMIZED CONTROL TRIAL DESIGN AND INTER-INSTITUTIONAL COLLABORATIVE EFFORTS | 1.1 | 1 | Citations (PDF) |
| 131 | Recommendations for the Management of Cerebral and Cerebellar Infarction With Swelling | 6.0 | 496 | Citations (PDF) |
| 132 | 72 Year Old Female with Leg Weakness | 4.3 | 0 | Citations (PDF) |
| 133 | Hemicraniectomy in the management of malignant middle cerebral artery infarction: Lessons from randomized, controlled trials 2014, 5, 72 | | 7 | Citations (PDF) |
| 134 | Extracellular vesicles as a platform for ‘liquid biopsy’ in glioblastoma patients | 3.2 | 117 | Citations (PDF) |
| 135 | Diffusion-Weighted Imaging in Cancer: Physical Foundations and Applications of Restriction Spectrum Imaging | 0.6 | 242 | Citations (PDF) |
| 136 | RNA-seq of 272 gliomas revealed a novel, recurrent <i>PTPRZ1-MET</i> fusion transcript in secondary glioblastomas | 4.6 | 374 | Citations (PDF) |
| 137 | Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study | 2.6 | 28 | Citations (PDF) |
| 138 | Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma | 1.7 | 142 | Citations (PDF) |
| 139 | A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas | 1.7 | 68 | Citations (PDF) |
| 140 | Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas | 1.7 | 19 | Citations (PDF) |
| 141 | Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma | 2.6 | 33 | Citations (PDF) |
| 142 | Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies | 2.6 | 1,303 | Citations (PDF) |
| 143 | 150 Gene Expression Analysis Revealed Distinct Physiology in G-CIMP+ and G-CIMP- Gliomas | 1.9 | 0 | Citations (PDF) |
| 144 | Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases: Table 1 | 7.3 | 116 | Citations (PDF) |
| 145 | ONYX versus n-BCA for embolization of cranial dural arteriovenous fistulas | 3.4 | 86 | Citations (PDF) |
| 146 | miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development | 2.4 | 318 | Citations (PDF) |
| 147 | BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles | 5.6 | 327 | Citations (PDF) |
| 148 | Neuro-oncologic Applications of Exosomes, Microvesicles, and Other Nano-Sized Extracellular Particles | 1.9 | 41 | Citations (PDF) |
| 149 | 78 Year Old Male with Dysphagia and Dysarthria | 4.3 | 0 | Citations (PDF) |
| 150 | Key concepts in glioblastoma therapy | 7.3 | 69 | Citations (PDF) |
| 151 | Frameless, Real-Time, Surface Imaging-Guided Radiosurgery | 1.9 | 63 | Citations (PDF) |
| 152 | Suppression of Human Glioma Xenografts with Second-Generation IL13R-Specific Chimeric Antigen Receptor–Modified T Cells | 6.9 | 129 | Citations (PDF) |
| 153 | CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy | 2.6 | 9 | Citations (PDF) |
| 154 | Post-transcriptional regulation of O6-methylguanine-DNA methyltransferase MGMT in glioblastomas | 1.6 | 41 | Citations (PDF) |
| 155 | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls | 3.1 | 185 | Citations (PDF) |
| 156 | A review of lumbar spinal instrumentation: evidence and controversy | 7.3 | 17 | Citations (PDF) |
| 157 | DNA Damage Response and Repair: Insights Into Strategies for Radiation Sensitization of Gliomas | 2.4 | 36 | Citations (PDF) |
| 158 | Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights | 2.6 | 47 | Citations (PDF) |
| 159 | Role of magnesium sulfate in aneurysmal subarachnoid hemorrhage management: A meta-analysis of controlled clinical trials | 1.2 | 17 | Citations (PDF) |
| 160 | Racial, Ethnic, and Socioeconomic Disparities in Patient Outcomes After Craniotomy for Tumor in Adult Patients in the United States, 1988–2004 | 1.9 | 184 | Citations (PDF) |
| 161 | Microfluidic isolation and transcriptome analysis of serum microvesicles | 5.2 | 525 | Citations (PDF) |
| 162 | Microsurgical Clip Obliteration of Middle Cerebral Aneurysm Using Intraoperative Flow Assessment | 0.3 | 2 | Citations (PDF) |
| 163 | Effective Glycemic Control With Aggressive Hyperglycemia Management Is Associated With Improved Outcome in Aneurysmal Subarachnoid Hemorrhage | 6.0 | 68 | Citations (PDF) |
| 164 | Genetically engineered T cells to target EGFRvIII expressing glioblastoma | 2.6 | 63 | Citations (PDF) |
| 165 | LONG-TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATION | 1.9 | 461 | Citations (PDF) |
| 166 | Standard Operating Procedures | 1.9 | 0 | Citations (PDF) |
| 167 | Surrogate Measures of Outcome in Clinical Trials | 1.9 | 2 | Citations (PDF) |
| 168 | Angiopoietin-1 increases survival and reduces the development of lung edema induced by endotoxin administration in a murine model of acute lung injury | 0.5 | 50 | Citations (PDF) |
| 169 | INCREASED PREVALENCE OF OBESITY AND OBESITY-RELATED POSTOPERATIVE COMPLICATIONS IN MALE PATIENTS WITH MENINGIOMAS | 1.9 | 34 | Citations (PDF) |
| 170 | High-dose Bosentan in the Prevention and Treatment of Subarachnoid Hemorrhage-induced Cerebral Vasospasm: An Open-label Feasibility Study | 2.8 | 10 | Citations (PDF) |
| 171 | Epidemiology of the Size Distribution of Intracranial Bifurcation Aneurysms: Smaller Size of Distal Aneurysms and Increasing Size of Unruptured Aneurysms with Age | 1.9 | 76 | Citations (PDF) |
| 172 | Noninvasive Bioluminescence Imaging of Luciferase Expressing Intracranial U87 Xenografts: Correlation with Magnetic Resonance Imaging Determined Tumor Volume and Longitudinal Use in Assessing Tumor Growth and Antiangiogenic Treatment Effect | 1.9 | 113 | Citations (PDF) |
| 173 | OUTCOMES FORSURGICAL AND ENDOVASCULARMANAGEMENT OF INTRACRANIAL ANEURYSMSUSING A COMPREHENSIVE GRADING SYSTEM | 1.9 | 46 | Citations (PDF) |
| 174 | Complications of Cerebral Arteriovenous Malformation Embolization: Multivariate Analysis of Predictive Factors | 1.9 | 173 | Citations (PDF) |
| 175 | Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage* | 0.5 | 186 | Citations (PDF) |
| 176 | Factors Associated with Outcome after Hemicraniectomy for Large Middle Cerebral Artery Territory Infarction | 1.9 | 105 | Citations (PDF) |
| 177 | Surgery for primary supratentorial brain tumors in the United States,
1988 to 2000: The effect of provider caseload and centralization of care | 1.1 | 146 | Citations (PDF) |
| 178 | Adult-Born and Preexisting Olfactory Granule Neurons Undergo Distinct Experience-Dependent Modifications of their Olfactory Responses<i>In Vivo</i> | 3.7 | 203 | Citations (PDF) |
| 179 | Case 5-2004 | 43.7 | 3 | Citations (PDF) |
| 180 | Achieving Normothermia in Patients With Febrile Subarachnoid Hemorrhage: Feasibility and Safety of a Novel Intravascular Cooling Catheter | 2.8 | 42 | Citations (PDF) |
| 181 | Age-dependent Differences in Short-term Outcome after Surgical or Endovascular Treatment of Unruptured Intracranial Aneurysms in the United States, 1996–2000 | 1.9 | 146 | Citations (PDF) |
| 182 | RESULTS OF A PROSPECTIVE PROTOCOL OF COMPUTED TOMOGRAPHIC ANGIOGRAPHY IN PLACE OF CATHETER ANGIOGRAPHY AS THE ONLY DIAGNOSTIC AND PRETREATMENT PLANNING STUDY FOR CEREBRAL ANEURYSMS BY A COMBINED NEUROVASCULAR TEAM | 1.9 | 217 | Citations (PDF) |
| 183 | Effect of Clipping, Craniotomy, or Intravascular Coiling on Cerebral Vasospasm and Patient Outcome after Aneurysmal Subarachnoid Hemorrhage | 1.9 | 122 | Citations (PDF) |
| 184 | Genetic and Cellular Therapies for Cerebral Infarction | 1.9 | 22 | Citations (PDF) |
| 185 | Hemicraniectomy for Massive Cerebral Infarction | 2.6 | 3 | Citations (PDF) |
| 186 | Surgical Excision of Acoustic Neuroma: Patient Outcome and Provider Caseload | 1.5 | 102 | Citations (PDF) |
| 187 | Microvascular Decompression Surgery in the United States, 1996 to 2000: Mortality Rates, Morbidity Rates, and the Effects of Hospital and Surgeon Volumes | 1.9 | 264 | Citations (PDF) |
| 188 | In-hospital Mortality and Morbidity after Surgical Treatment of Unruptured Intracranial Aneurysms in the United States, 1996–2000: The Effect of Hospital and Surgeon Volume | 1.9 | 93 | Citations (PDF) |
| 189 | Stratification of Outcome for Surgically Treated Unruptured Intracranial Aneurysms | 1.9 | 85 | Citations (PDF) |
| 190 | Important Factors for a Combined Neurovascular Team to Consider in Selecting a Treatment Modality for Patients with Previously Clipped Residual and Recurrent Intracranial Aneurysms | 1.9 | 48 | Citations (PDF) |
| 191 | In-hospital Mortality and Morbidity after Surgical Treatment of Unruptured Intracranial Aneurysms in the United States, 1996–2000: The Effect of Hospital and Surgeon Volume | 1.9 | 52 | Citations (PDF) |
| 192 | Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors | 7.6 | 122 | Citations (PDF) |
| 193 | Risk of Hemorrhage from Unsecured, Unruptured Aneurysms during and after Hypertensive Hypervolemic Therapy | 1.9 | 1 | Citations (PDF) |
| 194 | Proposed Use of Prophylactic Decompressive Craniectomy in Poor-grade Aneurysmal Subarachnoid Hemorrhage Patients Presenting with Associated Large Sylvian Hematomas | 1.9 | 173 | Citations (PDF) |
| 195 | Results of Multimodality Treatment for 141 Patients with Brain Arteriovenous Malformations and Seizures: Factors Associated with Seizure Incidence and Seizure Outcomes | 1.9 | 158 | Citations (PDF) |
| 196 | Risk of Hemorrhage from Unsecured, Unruptured Aneurysms during and after Hypertensive Hypervolemic Therapy | 1.9 | 35 | Citations (PDF) |
| 197 | Medical management of increased intracranial pressure after spontaneous intracerebral hemorrhage | 1.4 | 8 | Citations (PDF) |
| 198 | Results after Surgical and Endovascular Treatment of Paraclinoid Aneurysms by a Combined Neurovascular Team | 1.9 | 140 | Citations (PDF) |
| 199 | Results after Surgical and Endovascular Treatment of Paraclinoid Aneurysms by a Combined Neurovascular Team | 1.9 | 104 | Citations (PDF) |
| 200 | Subarachnoid hemorrhage | 0.6 | 1 | Citations (PDF) |
| 201 | Management Outcomes for Ruptured and Unruptured Aneurysms in the Elderly | 1.9 | 79 | Citations (PDF) |
| 202 | Factors Associated with Reintegration to Normal Living after Subarachnoid Hemorrhage | 1.9 | 126 | Citations (PDF) |
| 203 | A TVA–Single-Chain Antibody Fusion Protein Mediates Specific Targeting of a Subgroup A Avian Leukosis Virus Vector to Cells Expressing a Tumor-Specific Form of Epidermal Growth Factor Receptor | 3.7 | 31 | Citations (PDF) |
| 204 | BIOLOGICAL AGGRESSIVENESS OF HEREDITARY PROSTATE CANCER: LONG-TERM EVALUATION FOLLOWING RADICAL PROSTATECTOMY | 4.5 | 71 | Citations (PDF) |
| 205 | BIOLOGICAL AGGRESSIVENESS OF HEREDITARY PROSTATE CANCER | 4.5 | 4 | Citations (PDF) |
| 206 | One-year Outcome after Decompressive Surgery for Massive Nondominant Hemispheric Infarction | 1.9 | 248 | Citations (PDF) |
| 207 | Hereditary Prostate Cancer: Epidemiologic and Clinical Features | 4.5 | 536 | Citations (PDF) |
| 208 | Sexual Function following Radical Prostatectomy: Influence of Preservation of Neurovascular Bundles | 4.5 | 515 | Citations (PDF) |
| 209 | Epidemiologic evidence regarding predisposing factors to prostate cancer | 2.2 | 145 | Citations (PDF) |
| 210 | Family history and the risk of prostate cancer | 2.2 | 625 | Citations (PDF) |
| 211 | The role of extracellular vesicles in acquisition of resistance to therapy in glioblastomas 0, , | | 13 | Citations (PDF) |
